Breast tumour kinase, also known as protein tyrosine kinase 6 (Brk/PTK6) is overexpressed in a high proportion of invasive breast cancers, and represents a possible target for therapeutic intervention [1,2]. Here, PTK6 is linked to invasive breast carcinoma.